Ticker	Volume	Price	Price Delta
DJIA	15,303.10	+8.60	0.06%
S&P 500	1,649.60	-0.91	-0.06%
Nasdaq	3,459.14	-0.27	-0.01%

Ticker

Volume

Price

Price Delta

DJIA

15,303.10

+8.60

0.06%

S&P 500

1,649.60

-0.91

-0.06%

Nasdaq

3,459.14

-0.27

-0.01%

Ticker	Volume	Price	Price Delta
STOXX 50	2,764.29	-12.49	-0.45%
FTSE 100	6,654.34	-42.45	-0.63%
DAX	8,305.32	-46.66	-0.56%

Ticker

Volume

Price

Price Delta

STOXX 50

2,764.29

-12.49

-0.45%

FTSE 100

6,654.34

-42.45

-0.63%

DAX

8,305.32

-46.66

-0.56%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Exchange: London
Sector: Consumer, Non-cyclical
Industry: Pharmaceuticals
Sub-Industry: Medical-Whsle Drug Dist

United Drug PLC

+ Add to Watchlist

UDG:LN

326.800 GBp 1.800 0.55%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 11:35:14 ET on 05/24/2013.

Snapshot for United Drug PLC (UDG)

Open:	325.000	Day's Range:	323.000 - 328.000	Volume:	870,175
Previous Close:	326.800	52wk Range:	158.500 - 340.000	1-Yr Rtn:	+83.36%

Stock Chart for UDG

No chart data available.

UDG:LN 326.800

326.800

Interactive UDG Chart

…

Previous Close

Key Statistics for UDG

Current P/E Ratio (ttm)	19.1500
Estimated P/E(09/2013)	14.1611
Relative P/E vs. UKX	1.1504
Earnings Per Share (EUR) (ttm)	0.1996
Est. EPS (EUR) (09/2013)	0.2700
Est. PEG Ratio	-
Market Cap (M GBP)	784.97
Shares Outstanding (M)	240.20
30 Day Average Volume	306,031
Price/Book (mrq)	2.1376
Price/Sale (ttm)	0.4991
Dividend Indicated Gross Yield	2.29%
Cash Dividend (EUR)	0.0261
Last Dividend	05/15/2013
5 Year Dividend Growth	6.07%
Next Earnings Announcement	11/20/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UDG

Revenue
Net Income (M/EUR)

Profit Margin (%)

Company Profile & Key Executives for UDG

United Drug PLC provides commercialisation solutions for healthcare companies. The Company operates through the following divisions: Healthcare Supply Chain, Sales, Marketing & Medical, Packaging & Speciality. UDG serves its clients from operations in the UK, US, Cont. Europe and Ireland. The Company enables healthcare companies to outsource non-core, fixed cost activities.